Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001817746 | SCV002069115 | pathogenic | not provided | 2018-03-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001817746 | SCV002169603 | pathogenic | not provided | 2023-11-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val74Glyfs*2) in the TYR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TYR are known to be pathogenic (PMID: 23504663). This variant is present in population databases (rs767003400, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TYR-related conditions. ClinVar contains an entry for this variant (Variation ID: 1338375). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003470930 | SCV004207589 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2023-08-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001817746 | SCV005390050 | pathogenic | not provided | 2024-04-29 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 34838614, 37217489) |